PubRank

Wolfgang Dietmaier

Author PubWeight™ 71.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 2012 2.59
2 Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009 2.22
3 Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem 2004 2.17
4 Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 2007 2.02
5 Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006 1.70
6 Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer. Proc Natl Acad Sci U S A 2006 1.64
7 General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res 2010 1.64
8 No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients. Eur J Hum Genet 2008 1.58
9 CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 2008 1.56
10 Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study. Int J Colorectal Dis 2006 1.54
11 Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet 2012 1.40
12 Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res 2007 1.33
13 Different types of microsatellite instability in ovarian carcinoma. Int J Cancer 2004 1.30
14 Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther 2007 1.29
15 Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 2006 1.29
16 Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol 2004 1.26
17 Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur J Hum Genet 2008 1.25
18 Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J 2006 1.25
19 Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res 2002 1.20
20 Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 2004 1.19
21 The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 2007 1.11
22 Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer 2006 1.11
23 Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol 2007 1.10
24 Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol 2009 1.07
25 Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol 2005 1.03
26 Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma. Hum Pathol 2005 1.02
27 Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era. Am J Clin Pathol 2005 1.02
28 Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol Rep 2007 1.01
29 Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors. BMC Med Genet 2010 1.01
30 Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation. Virchows Arch 2007 1.01
31 Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol 2005 1.00
32 Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. BMC Cancer 2010 0.96
33 Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. J Clin Pathol 2011 0.95
34 Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test 2005 0.93
35 Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation. Int J Cancer 2012 0.91
36 Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res 2007 0.91
37 Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. J Mol Diagn 2005 0.90
38 T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis. Cancer Res 2002 0.89
39 Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. Lancet Oncol 2005 0.89
40 Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin. Lab Invest 2005 0.88
41 Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation. Int J Oncol 2003 0.88
42 Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection. Ann Surg 2011 0.86
43 Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer. J Clin Pathol 2006 0.86
44 Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hum Pathol 2003 0.85
45 Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater. Mod Pathol 2008 0.85
46 Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. J Mol Diagn 2005 0.83
47 Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue. Hum Mutat 2004 0.83
48 Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation. Clin Cancer Res 2004 0.83
49 Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines. World J Gastroenterol 2006 0.82
50 Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI). Cancer Lett 2004 0.82
51 Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater. Virchows Arch 2008 0.82
52 Genomic instability at both the base pair level and the chromosomal level is detectable in earliest PanIN lesions in tissues of chronic pancreatitis. Pancreas 2010 0.82
53 Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Arch Pathol Lab Med 2003 0.82
54 Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder. Am J Clin Pathol 2010 0.82
55 Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium. Am J Clin Pathol 2005 0.82
56 Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort. Exp Dermatol 2011 0.81
57 Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis. Mod Pathol 2002 0.81
58 MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples. Lab Invest 2008 0.81
59 Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome. Arch Pathol Lab Med 2004 0.81
60 ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition. Gastroenterology 2009 0.81
61 MSI-testing in hereditary non-polyposis colorectal carcinoma (HNPCC). Dis Markers 2004 0.80
62 Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas. Langenbecks Arch Surg 2007 0.79
63 Molecular genetic analysis excludes implantation metastasis of basal cell carcinomas. Arch Pathol Lab Med 2003 0.77
64 Expression of carbonic anhydrase IX in craniopharyngiomas. J Neurosurg 2011 0.77
65 Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors. Eur Arch Otorhinolaryngol 2013 0.77
66 Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis. Am J Dermatopathol 2014 0.76
67 Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors. Fam Cancer 2012 0.75
68 Laser microdissection for microsatellite analysis in colon and breast cancer. Methods Mol Biol 2005 0.75
69 Multiple molecular analyses from minimal cell quantities by sequential isolation and preamplification of DNA and RNA. Diagn Mol Pathol 2007 0.75
70 Microdissection for detecting genetic aberrations in early and advanced human urinary bladder cancer. Methods Mol Biol 2005 0.75